AbbVie Bid for Biotech Could Expand with Experimental Drug
AbbVie is exploring a cash purchase of about $10.9 billion for a biotech developing an experimental eczema drug, a mo...
Understanding the value of credit card points versus cash back will help you make informed financial decisions. Discover which option gives you better returns.
26,454 articlesAbbVie is exploring a cash purchase of about $10.9 billion for a biotech developing an experimental eczema drug, a mo...
Vistra reports record 2025 EBITDA and unveils a 2026 target that points to sustained growth. The company cites long-t...
The 2027 COLA could lift benefits, but rising Medicare costs and hold-harmless rules mean many retirees may see littl...
Disruption is reshaping markets faster than ever. This article digs into disruption stories: stocks that could be at ...
Micron Technology surged to a fresh all-time high after a blockbuster earnings report and strong AI-driven demand. Th...
A few well-timed picks can dramatically change a portfolio. This guide breaks down what to look for and presents thre...
Strategy reveals a potential strategy sell $1.25 billion in Bitcoin to strengthen liquidity and investor confidence a...
Two tech powerhouses sit at the AI crossroads. This article breaks down the nvidia stock micron stock dynamic, what h...
A memory stock that looked ordinary just a year ago has stunned investors with an 8x move. Now Wall Street is unanimo...
Insider activity can shed light on a company's future. This deep dive examines Perdoceo Education's $1.8 million insi...
Start with a $1,000 investment and position it for two decades of AI-driven growth. This guide explains why Microsoft...
Unlock the value hidden in the 2026 earnings call transcript. This guide shows you how to parse management commentary...